Bioprinting is a biomedical key technology that has the potential to improve medical patient treatment in multiple ways.
Bioprinted tissue analogues, such as skin, liver, or heart muscle patches, resemble native organ function more closely than conventional cell cultures. Using these models for drug and toxicity screening, time and resources for development of novel pharmaceutics can dramatically be decreased. Moreover, building tissue models from patient derived cells enables tailored therapies with reduced side-effects.
In the future bioprinted tissue implants could be used to maintain, restore, or substitute the function of damaged tissues.